Publicaciones científicas sobre los diagnósticos no invasivos de BioPredictive

An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver. Key publication

Myers RP et al. · Can J Gastroenterol · 2012 Coinc. 100

…approved protease inhibitors (boceprevir and telaprevir), including those who have previously failed…

FibroTest HCV

Successful treatment with telaprevir-based regimens for chronic hepatitis C results in significant improvements to serum markers of liver fibrosis.

Haseltine EL et al. · J Viral Hepat · 2015 Coinc. 97

…1208 patients treated with a telaprevir-based regimen were included in the…

FibroTest HCV

Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients.

Liu S et al. · PLoS One · 2011 Coinc. 94

…women) with the addition of telaprevir. For genotypes 2 and 3, treatment…

FibroTest HCV

Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection Key publication

· 2014 Coinc. 90

These are the first guidelines dealing with hepatitis C treatment produced by…

FibroTest HCV

The new paradigm of hepatitis C therapy: integration of oral therapies into best practices. Review

Afdhal NH et al. · J Viral Hepat · 2013 Coinc. 87

Emerging data indicate that all-oral antiviral treatments for chronic hepatitis C…

ActiTest FibroTest HCV

EASL Clinical Practice Guidelines: management of hepatitis C virus infection.

European Association for the Study of the Liver · J Hepatol · 2011 Coinc. 84

ActiTest FibroTest HCV

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Key publication

AASLD/IDSA HCV Guidance Panel · Hepatology · 2015 Coinc. 80

ActiTest FibroTest HCV

Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: a randomized study.

Poynard T et al. · J Hepatol · 2013 Coinc. 77

### Background & Aims Therapeutic options for patients failing hepatitis C retreatment are limited…

ActiTest FibroTest HBV

Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis.

Asselah T et al. · Liver Int · 2018 Coinc. 74

### Background & Aims Patients with chronic hepatitis C virus infection and advanced fibrosis…

FibroTest HCV

Is it possible to predict HCV-related liver cirrhosis non-invasively through routine laboratory parameters? Review

Gentile I et al. · Infez Med · 2014 Coinc. 70

It is estimated that hepatitis C virus (HCV) infects chronically about 160…

FibroTest HCV

Real-world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis.

Preda CM et al. · Liver Int · 2018 Coinc. 67

### Background Direct antiviral agents (DAA) showed very good results in terms of…

FibroTest HCV

Prise en charge des personnes infectées par les virus de l’hépatite B ou de l’hépatite C — Rapport de recommandations 2014 Key publication

Coinc. 64

FibroTest HBV HCV

Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection.

Akuta N et al. · J Gastroenterol · 2018 Coinc. 60

### Background In the UNITY-3 study, 96% sustained virologic response (SVR12) rate…

FibroTest HCV

Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey.

Sebastiani G et al. · Can J Gastroenterol Hepatol · 2014 Coinc. 57

### Objective To determine practices among physicians in Canada for the assessment of…

FibroTest Alcohol HBV HCV +3

Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness. Review

Stasi C et al. · World J Gastroenterol · 2016 Coinc. 54

The assessment of the fibrotic evolution of chronic hepatitis has always been…

FibroTest HCV